ロート製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/01/17 | 3,175 | 3,245 | 3,175 | 3,220 | +50 | +1.6% | 198,400 |
2022/01/14 | 3,220 | 3,225 | 3,120 | 3,170 | -75 | -2.3% | 270,500 |
2022/01/13 | 3,365 | 3,365 | 3,245 | 3,245 | -120 | -3.6% | 172,800 |
2022/01/12 | 3,360 | 3,380 | 3,350 | 3,365 | +35 | +1.1% | 138,900 |
2022/01/11 | 3,345 | 3,345 | 3,290 | 3,330 | +5 | +0.2% | 184,500 |
2022/01/07 | 3,370 | 3,385 | 3,295 | 3,325 | -40 | -1.2% | 151,200 |
2022/01/06 | 3,415 | 3,450 | 3,360 | 3,365 | -100 | -2.9% | 158,500 |
2022/01/05 | 3,480 | 3,485 | 3,445 | 3,465 | -25 | -0.7% | 158,900 |
2022/01/04 | 3,500 | 3,515 | 3,460 | 3,490 | +15 | +0.4% | 106,800 |
2021/12/30 | 3,455 | 3,500 | 3,455 | 3,475 | -30 | -0.9% | 76,900 |
2021/12/29 | 3,510 | 3,540 | 3,485 | 3,505 | +10 | +0.3% | 148,500 |
2021/12/28 | 3,435 | 3,510 | 3,435 | 3,495 | +30 | +0.9% | 147,500 |
2021/12/27 | 3,495 | 3,495 | 3,455 | 3,465 | +5 | +0.1% | 91,800 |
2021/12/24 | 3,475 | 3,475 | 3,435 | 3,460 | -15 | -0.4% | 83,500 |
2021/12/23 | 3,550 | 3,565 | 3,470 | 3,475 | -5 | -0.1% | 152,400 |
2021/12/22 | 3,485 | 3,515 | 3,465 | 3,480 | -5 | -0.1% | 224,100 |
2021/12/21 | 3,450 | 3,515 | 3,440 | 3,485 | +85 | +2.5% | 204,800 |
2021/12/20 | 3,370 | 3,430 | 3,370 | 3,400 | -40 | -1.2% | 146,700 |
2021/12/17 | 3,480 | 3,490 | 3,420 | 3,440 | -35 | -1% | 175,600 |
2021/12/16 | 3,510 | 3,525 | 3,445 | 3,475 | +50 | +1.5% | 169,800 |
2021/12/15 | 3,435 | 3,475 | 3,425 | 3,425 | -10 | -0.3% | 118,300 |
2021/12/14 | 3,470 | 3,485 | 3,435 | 3,435 | +30 | +0.9% | 196,500 |
2021/12/13 | 3,455 | 3,470 | 3,405 | 3,405 | -25 | -0.7% | 169,100 |
2021/12/10 | 3,415 | 3,460 | 3,405 | 3,430 | +35 | +1% | 230,200 |
2021/12/09 | 3,415 | 3,465 | 3,395 | 3,395 | -30 | -0.9% | 164,400 |
2021/12/08 | 3,455 | 3,475 | 3,425 | 3,425 | +10 | +0.3% | 309,700 |
2021/12/07 | 3,325 | 3,420 | 3,310 | 3,415 | +110 | +3.3% | 211,500 |
2021/12/06 | 3,275 | 3,320 | 3,275 | 3,305 | +30 | +0.9% | 206,600 |
2021/12/03 | 3,180 | 3,275 | 3,155 | 3,275 | +65 | +2% | 220,000 |
2021/12/02 | 3,160 | 3,240 | 3,160 | 3,210 | +20 | +0.6% | 209,300 |
2021/12/01 | 3,210 | 3,210 | 3,165 | 3,190 | -45 | -1.4% | 250,000 |
2021/11/30 | 3,315 | 3,355 | 3,225 | 3,235 | -55 | -1.7% | 353,600 |
2021/11/29 | 3,285 | 3,325 | 3,280 | 3,290 | -65 | -1.9% | 220,800 |
2021/11/26 | 3,370 | 3,390 | 3,350 | 3,355 | -15 | -0.4% | 167,000 |
2021/11/25 | 3,365 | 3,410 | 3,355 | 3,370 | +30 | +0.9% | 185,200 |
2021/11/24 | 3,325 | 3,360 | 3,325 | 3,340 | -45 | -1.3% | 231,200 |
2021/11/22 | 3,320 | 3,410 | 3,310 | 3,385 | +20 | +0.6% | 211,400 |
2021/11/19 | 3,305 | 3,380 | 3,305 | 3,365 | +70 | +2.1% | 367,800 |
2021/11/18 | 3,205 | 3,320 | 3,205 | 3,295 | +55 | +1.7% | 293,700 |
2021/11/17 | 3,285 | 3,290 | 3,240 | 3,240 | -65 | -2% | 169,500 |
2021/11/16 | 3,295 | 3,355 | 3,290 | 3,305 | -5 | -0.2% | 315,800 |
2021/11/15 | 3,365 | 3,405 | 3,310 | 3,310 | -115 | -3.4% | 366,600 |
2021/11/12 | 3,500 | 3,505 | 3,375 | 3,425 | +30 | +0.9% | 389,800 |
2021/11/11 | 3,355 | 3,420 | 3,355 | 3,395 | -25 | -0.7% | 267,000 |
2021/11/10 | 3,415 | 3,450 | 3,400 | 3,420 | +15 | +0.4% | 179,100 |
2021/11/09 | 3,410 | 3,425 | 3,390 | 3,405 | -35 | -1% | 203,900 |
2021/11/08 | 3,460 | 3,475 | 3,435 | 3,440 | -65 | -1.9% | 161,400 |
2021/11/05 | 3,465 | 3,515 | 3,465 | 3,505 | +5 | +0.1% | 137,000 |
2021/11/04 | 3,505 | 3,515 | 3,475 | 3,500 | ±0 | ±0% | 242,300 |
2021/11/02 | 3,500 | 3,515 | 3,465 | 3,500 | -70 | -2% | 226,400 |
701~
750
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ロート」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム